Home » Topics » Regulatory » Patents

Patents
RSS

Anvyl presents deuterated etifoxine analogs

Oct. 14, 2016

Vertex Pharmaceuticals develops PAR2 antagonists

Oct. 14, 2016

McGill University and Florida Institute of Technology describe OXER1 antagonists

Oct. 14, 2016

Sichuan Kelun Pharmaceutical Research discloses anticancer agents

Oct. 14, 2016

Shenyang Sunshine Pharmaceutical patents PHD2 inhibitors

Oct. 14, 2016

Takeda Pharmaceutical presents EIT6 inhibitors

Oct. 13, 2016

BioNTech develops seprase binding peptides

Oct. 13, 2016

ChemBridge describes GPR131 agonists

Oct. 13, 2016

Abide Therapeutics discloses monoacylglycerol lipase inhibitors

Oct. 13, 2016

Bristol-Myers Squibb patents TNF-alpha antagonists

Oct. 13, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...